X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs WOCKHARDT LTD. - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS WOCKHARDT LTD. NOVARTIS/
WOCKHARDT LTD.
 
P/E (TTM) x 393.4 -18.2 - View Chart
P/BV x 19.4 3.0 648.8% View Chart
Dividend Yield % 1.5 1.1 134.9%  

Financials

 NOVARTIS   WOCKHARDT LTD.
EQUITY SHARE DATA
    NOVARTIS
Mar-16
WOCKHARDT LTD.
Mar-17
NOVARTIS/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs9821,129 87.0%   
Low Rs556627 88.7%   
Sales per share (Unadj.) Rs252.9363.1 69.6%  
Earnings per share (Unadj.) Rs62.1-20.4 -303.9%  
Cash flow per share (Unadj.) Rs63.3-7.0 -907.4%  
Dividends per share (Unadj.) Rs10.0010.00 100.0%  
Dividend yield (eoy) %1.31.1 114.2%  
Book value per share (Unadj.) Rs363.6301.8 120.5%  
Shares outstanding (eoy) m31.96110.55 28.9%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x3.02.4 125.8%   
Avg P/E ratio x12.4-42.9 -28.8%  
P/CF ratio (eoy) x12.2-125.9 -9.7%  
Price / Book Value ratio x2.12.9 72.7%  
Dividend payout %16.1-48.9 -32.9%   
Avg Mkt Cap Rs m24,58097,063 25.3%   
No. of employees `0000.86.8 11.1%   
Total wages/salary Rs m1,8019,665 18.6%   
Avg. sales/employee Rs Th10,748.95,931.8 181.2%   
Avg. wages/employee Rs Th2,395.21,428.1 167.7%   
Avg. net profit/employee Rs Th2,641.1-334.0 -790.8%   
INCOME DATA
Net Sales Rs m8,08340,146 20.1%  
Other income Rs m8291,143 72.6%   
Total revenues Rs m8,91341,289 21.6%   
Gross profit Rs m234128 183.0%  
Depreciation Rs m371,489 2.5%   
Interest Rs m22,253 0.1%   
Profit before tax Rs m1,025-2,472 -41.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,6960-   
Tax Rs m752-211 -356.2%   
Profit after tax Rs m1,986-2,260 -87.9%  
Gross profit margin %2.90.3 908.7%  
Effective tax rate %73.48.5 858.9%   
Net profit margin %24.6-5.6 -436.4%  
BALANCE SHEET DATA
Current assets Rs m12,67846,160 27.5%   
Current liabilities Rs m2,43319,258 12.6%   
Net working cap to sales %126.767.0 189.1%  
Current ratio x5.22.4 217.4%  
Inventory Days Days33101 32.5%  
Debtors Days Days2294 23.9%  
Net fixed assets Rs m6940,165 0.2%   
Share capital Rs m160553 28.9%   
"Free" reserves Rs m11,46032,814 34.9%   
Net worth Rs m11,62133,367 34.8%   
Long term debt Rs m031,903 0.0%   
Total assets Rs m14,40089,687 16.1%  
Interest coverage x570.5-0.1 -587,369.9%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.60.4 125.4%   
Return on assets %13.80 -160,799.8%  
Return on equity %17.1-6.8 -252.3%  
Return on capital %23.6-0.3 -7,033.1%  
Exports to sales %0.70-   
Imports to sales %18.60-   
Exports (fob) Rs m60NA-   
Imports (cif) Rs m1,503NA-   
Fx inflow Rs m1869,121 2.0%   
Fx outflow Rs m1,8212,133 85.4%   
Net fx Rs m-1,6356,988 -23.4%   
CASH FLOW
From Operations Rs m2,531-2,695 -93.9%  
From Investments Rs m-8,270-6,863 120.5%  
From Financial Activity Rs m-38612,545 -3.1%  
Net Cashflow Rs m-6,1253,010 -203.5%  

Share Holding

Indian Promoters % 0.0 74.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 2.3 87.0%  
FIIs % 1.6 7.7 20.8%  
ADR/GDR % 0.0 0.1 -  
Free float % 21.5 15.4 139.6%  
Shareholders   41,647 67,757 61.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   AJANTA PHARMA  FDC LTD.  SUN PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jan 19, 2018 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS